Contact
Leslie L. Citrome, M.D., M.P.H., is a distinguished life fellow of the American Psychiatric Association and a fellow of the American Society of Clinical Psychopharmacology, where he currently serves as immediate past president. He is a volunteer consultant to the Assertive Community Treatment team/Mental Health Association of Rockland County. In 2019, Dr. Citrome received the New York Medical College Faculty Author Award for “First Authorship Who Published in the Most Open Access Journals (Web of Science)”. In 2018, 2021, and 2023, Dr. Citrome was recognized as the Voluntary Faculty Teacher of the Year in the Department of Psychiatry and Behavioral Sciences at New York Medical College/Westchester Medical Center.
Dr. Citrome is currently a consultant in clinical trial design and interpretation. He is a frequent lecturer on the quantitative assessment of clinical trial results, including the metrics of the number needed to treat and the number needed to harm, and has lectured throughout the Americas, Europe, Asia, and Australia. Dr. Citrome’s main interests include schizophrenia, bipolar disorder, and major depressive disorder. He is an author and co-author of more than 600 research reports, reviews, and chapters in the scientific literature. He is a member of the Board of Directors of the World Association of Medical Editors. Dr. Citrome is editor-in-chief of Current Medical Research and Opinion (CMRO) published by Taylor & Francis; psychiatry topic editor for Clinical Therapeutics; editor for the American Society of Clinical Psychopharmacology Corner in the Journal of Clinical Psychiatry; and also serves as an editorial board member for 11 other journals.
Education
- Residency, Psychiatry, New York University
- M.D., McGill University Faculty of Medicine
- M.P.H., Columbia University School of Public Health
- DEC, Pure and Applied Science, Dawson College
Areas of Expertise
- Mental Health Disorders
Publications
- Abraham I, Hiligsmann M, Lee KKC, et. al. "What to expect in 2026-2027: important health economics and outcomes research topics." Expert review of pharmacoeconomics & outcomes research, (), (2026) 1-7. doi: 10.1080/14737167.2026.2692271
- Abraham I, Hiligsmann M, Lee KKC, et. al. "What to Expect in 2026-2027: Important Health Economics and Outcomes Research Topics." ClinicoEconomics and outcomes research : CEOR, 18(), (2026) 594790. doi: 10.2147/CEOR.S594790
- Abraham I, Hiligsmann M, Lee KKC, et. al. "What to expect in 2026-2027: important health economics and outcomes research topics." Current medical research and opinion, (), (2026) 1-9. doi: 10.1080/03007995.2026.2692753
- Abraham I, Hiligsmann M, Lee KKC, et. al. "What to expect in 2026-2027: important health economics and outcomes research topics." Journal of medical economics, 29(1), (2026) 2010-2019. doi: 10.1080/13696998.2026.2692757
- Goldberg JF, Crismon ML, Goodman DW, et. al. "When Do Physical Symptoms After Antidepressant Cessation Reflect Pharmacodynamic versus Non-pharmacodynamic Clinical Phenomena?" The Journal of clinical psychiatry, 87(4), (2026) . pii: 26ac16648. doi: 10.4088/JCP.26ac16648
- Citrome L, Farovik A, Palma AM, et. al. "Effects of Brexpiprazole on Functioning in Patients With Schizophrenia Who Have Hostility and Agitation Symptoms: Post Hoc Analysis of Short- and Long-Term Trials." The Journal of clinical psychiatry, 87(3), (2026) . pii: 26m16448. doi: 10.4088/JCP.26m16448
- Citrome L, Zhang Z, Hutson Walker AM, et. al. "Aripiprazole once-monthly for patients diagnosed with bipolar I disorder: Number needed to treat, number needed to harm, and likelihood to be helped or harmed." Journal of affective disorders, 413(), (2026) 122190. doi: 10.1016/j.jad.2026.122190
Memberships and Affiliations
- Distinguished Life Fellow of the American Psychiatric Association
- Fellow of the American Society of Clinical Psychopharmacology
- Fellow (Emeritus), Collegium Internationale Neuro-Psychopharmacologicum (CINP)
